|
cellular response to dna damage stimulus
|
GO:0006974 |
223 |
0.263
|
|
|
nuclear division
|
GO:0000280 |
332 |
0.175
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
166 |
0.129
|
|
|
transcription from rna polymerase ii promoter
|
GO:0006366 |
368 |
0.101
|
|
|
regulation of cell cycle
|
GO:0051726 |
291 |
0.071
|
|
|
endocytosis
|
GO:0006897 |
310 |
0.067
|
|
|
gene silencing
|
GO:0016458 |
138 |
0.063
|
|
|
ncrna 3 end processing
|
GO:0043628 |
17 |
0.061
|
|
|
phagocytosis
|
GO:0006909 |
215 |
0.061
|
|
|
rna processing
|
GO:0006396 |
147 |
0.060
|
|
|
mitotic g2 m transition checkpoint
|
GO:0044818 |
70 |
0.057
|
|
|
vesicle mediated transport
|
GO:0016192 |
381 |
0.056
|
|
|
positive regulation of macromolecule metabolic process
|
GO:0010604 |
405 |
0.056
|
|
|
positive regulation of rna metabolic process
|
GO:0051254 |
271 |
0.049
|
|
|
regulation of transcription from rna polymerase ii promoter
|
GO:0006357 |
378 |
0.047
|
|
|
negative regulation of gene expression
|
GO:0010629 |
387 |
0.040
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
93 |
0.039
|
|
|
rna 3 end processing
|
GO:0031123 |
45 |
0.038
|
|
|
regulation of cell cycle process
|
GO:0010564 |
181 |
0.035
|
|
|
regulation of gene expression epigenetic
|
GO:0040029 |
128 |
0.034
|
|
|
dendrite development
|
GO:0016358 |
204 |
0.033
|
|
|
mrna processing
|
GO:0006397 |
104 |
0.032
|
|
|
single organism cellular localization
|
GO:1902580 |
180 |
0.032
|
|
|
g2 dna damage checkpoint
|
GO:0031572 |
69 |
0.031
|
|
|
regulation of localization
|
GO:0032879 |
275 |
0.031
|
|
|
nucleobase containing compound catabolic process
|
GO:0034655 |
165 |
0.029
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
109 |
0.029
|
|
|
positive regulation of gene expression
|
GO:0010628 |
290 |
0.029
|
|
|
negative regulation of cellular metabolic process
|
GO:0031324 |
382 |
0.029
|
|
|
protein complex biogenesis
|
GO:0070271 |
201 |
0.028
|
|
|
regionalization
|
GO:0003002 |
416 |
0.028
|
|
|
ncrna processing
|
GO:0034470 |
30 |
0.028
|
|
|
snrna 3 end processing
|
GO:0034472 |
14 |
0.027
|
|
|
growth
|
GO:0040007 |
359 |
0.027
|
|
|
positive regulation of transcription from rna polymerase ii promoter
|
GO:0045944 |
204 |
0.026
|
|
|
imaginal disc derived appendage morphogenesis
|
GO:0035114 |
395 |
0.026
|
|
|
ncrna metabolic process
|
GO:0034660 |
43 |
0.026
|
|
|
appendage development
|
GO:0048736 |
401 |
0.025
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
152 |
0.024
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
86 |
0.024
|
|
|
regulation of protein metabolic process
|
GO:0051246 |
256 |
0.024
|
|
|
dna integrity checkpoint
|
GO:0031570 |
81 |
0.024
|
|
|
positive regulation of rna biosynthetic process
|
GO:1902680 |
266 |
0.023
|
|
|
macromolecular complex assembly
|
GO:0065003 |
256 |
0.023
|
|
|
nuclear transport
|
GO:0051169 |
72 |
0.023
|
|
|
leg disc morphogenesis
|
GO:0007478 |
80 |
0.021
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
168 |
0.021
|
|
|
chromatin organization
|
GO:0006325 |
207 |
0.020
|
|
|
positive regulation of transcription dna templated
|
GO:0045893 |
266 |
0.020
|
|
|
mitotic g2 dna damage checkpoint
|
GO:0007095 |
69 |
0.020
|
|
|
positive regulation of macromolecule biosynthetic process
|
GO:0010557 |
283 |
0.019
|
|
|
positive regulation of nitrogen compound metabolic process
|
GO:0051173 |
354 |
0.018
|
|
|
chromosome organization
|
GO:0051276 |
360 |
0.017
|
|
|
covalent chromatin modification
|
GO:0016569 |
106 |
0.017
|
|
|
muscle structure development
|
GO:0061061 |
224 |
0.017
|
|
|
cellular macromolecule localization
|
GO:0070727 |
220 |
0.017
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
165 |
0.016
|
|
|
protein complex assembly
|
GO:0006461 |
200 |
0.016
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
88 |
0.016
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
103 |
0.016
|
|
|
negative regulation of nucleic acid templated transcription
|
GO:1903507 |
240 |
0.016
|
|
|
transcription initiation from rna polymerase ii promoter
|
GO:0006367 |
25 |
0.016
|
|
|
positive regulation of response to stimulus
|
GO:0048584 |
323 |
0.016
|
|
|
organelle fission
|
GO:0048285 |
340 |
0.015
|
|
|
mrna metabolic process
|
GO:0016071 |
124 |
0.015
|
|
|
chromatin silencing
|
GO:0006342 |
76 |
0.015
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
93 |
0.015
|
|
|
regulation of hemocyte proliferation
|
GO:0035206 |
37 |
0.015
|
|
|
regulation of protein localization
|
GO:0032880 |
76 |
0.015
|
|
|
dendrite morphogenesis
|
GO:0048813 |
199 |
0.015
|
|
|
protein localization to organelle
|
GO:0033365 |
82 |
0.014
|
|
|
dna damage checkpoint
|
GO:0000077 |
78 |
0.014
|
|
|
reproductive system development
|
GO:0061458 |
74 |
0.013
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
103 |
0.013
|
|
|
regulation of organelle organization
|
GO:0033043 |
196 |
0.013
|
|
|
response to external biotic stimulus
|
GO:0043207 |
293 |
0.013
|
|
|
camera type eye development
|
GO:0043010 |
4 |
0.013
|
|
|
regulation of cellular protein metabolic process
|
GO:0032268 |
243 |
0.013
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
63 |
0.013
|
|
|
mitotic nuclear division
|
GO:0007067 |
213 |
0.013
|
|
|
snrna processing
|
GO:0016180 |
14 |
0.013
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
39 |
0.012
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
127 |
0.012
|
|
|
organonitrogen compound metabolic process
|
GO:1901564 |
318 |
0.012
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
116 |
0.012
|
|
|
positive regulation of nucleic acid templated transcription
|
GO:1903508 |
266 |
0.012
|
|
|
macromolecule catabolic process
|
GO:0009057 |
161 |
0.012
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
36 |
0.012
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
130 |
0.012
|
|
|
mitotic dna integrity checkpoint
|
GO:0044774 |
75 |
0.012
|
|
|
heterocycle catabolic process
|
GO:0046700 |
166 |
0.012
|
|
|
positive regulation of nucleobase containing compound metabolic process
|
GO:0045935 |
332 |
0.012
|
|
|
cellular protein modification process
|
GO:0006464 |
438 |
0.011
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
88 |
0.011
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
136 |
0.011
|
|
|
meiotic nuclear division
|
GO:0007126 |
151 |
0.011
|
|
|
protein dna complex assembly
|
GO:0065004 |
63 |
0.011
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
47 |
0.011
|
|
|
axis specification
|
GO:0009798 |
167 |
0.011
|
|
|
nuclear import
|
GO:0051170 |
51 |
0.011
|
|
|
appendage morphogenesis
|
GO:0035107 |
397 |
0.011
|
|
|
ras protein signal transduction
|
GO:0007265 |
88 |
0.011
|
|
|
positive regulation of cell communication
|
GO:0010647 |
250 |
0.010
|
|
|
cellular protein localization
|
GO:0034613 |
160 |
0.010
|
|
|
carbohydrate derivative metabolic process
|
GO:1901135 |
217 |
0.010
|
|
|
ribonucleoprotein complex biogenesis
|
GO:0022613 |
31 |
0.010
|
|
|
gene silencing by rna
|
GO:0031047 |
57 |
0.010
|
|
|
negative regulation of gene expression epigenetic
|
GO:0045814 |
77 |
0.010
|
|
|
intermediate filament cytoskeleton organization
|
GO:0045104 |
1 |
0.010
|
|
|
positive regulation of cellular biosynthetic process
|
GO:0031328 |
316 |
0.010
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
87 |
0.010
|
|